AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Atnospas MF 80mg/250mg Tablet

Prescription Icon
Prescription Required

Marketer

Aitne Lifesciences

Salt Composition

Drotaverine (80mg) + Mefenamic Acid (250mg)

Overview Atnospas MF 80mg/250mg Tablet

Gastro-intestinal relief is provided by the combined action of the components in AbdominalEase 80mg/250mg tablets, effectively managing abdominal pain. This medication alleviates bloating, discomfort, and cramping by relaxing stomach and intestinal muscles, while simultaneously inhibiting pain-inducing neurotransmitters. Dosage and duration of AbdominalEase 80mg/250mg tablets, administered with food, should strictly adhere to your physician's instructions. Treatment should continue as prescribed; premature cessation may lead to symptom recurrence and condition exacerbation. Inform your doctor of all other medications you are currently using, as interactions may occur. Common, usually transient, side effects include nausea, vomiting, diarrhea, stomach upset, dry mouth, appetite loss, thirst, and heartburn. Report any concerning side effects immediately to your doctor. Dizziness and somnolence are possible; avoid driving or activities demanding alertness until the medication's effects are known. Alcohol consumption should be avoided due to potential increased dizziness. If pregnant, planning pregnancy, breastfeeding, or experiencing liver or kidney issues, consult your physician before commencing treatment to ensure appropriate dosage.

Primary Ingredients of Atnospas MF 80mg/250mg Tablet

No text provided to rephrase.

Uses of Atnospas MF 80mg/250mg Tablet

Managing abdominal discomfort

Major Benefits of Atnospas MF 80mg/250mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Atnospas MF 80mg/250mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Atnospas MF 80mg/250mg Tablet:

  • Nausea
  • Vomiting
  • Diarrhea
  • Dryness in mouth
  • Heartburn
  • Vertigo
  • Insomnia (difficulty in sleeping)
  • Hypotension (low blood pressure)
  • Fast heart rate
  • Sweating
  • Constipation
  • Increased liver enzymes
  • Increased white blood cell count (eosinophils)
  • Decreased white blood cell count (lymphocytes)
  • Low blood platelets
  • Purpura
  • Agranulocytosis (deficiency of granulocytes in the blood)
  • Breathlessness
  • Ringing in ear
  • Abdominal pain
  • Flatulence
  • Indigestion
  • Stomach inflammation
  • Confusion
  • Depression

How to use Atnospas MF 80mg/250mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Atnospas MF 80mg/250mg tablets should be administered with food.

How Atnospas MF 80mg/250mg Tablet works:

The combined analgesic Atnospas MF 80mg/250mg Tablet uses drotaverine and mefenamic acid to alleviate abdominal pain and cramping. Drotaverine, an antispasmodic, targets and reduces abdominal smooth muscle contractions. Mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for abdominal pain and inflammation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Atnospas MF 80mg/250mg tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Atnospas MF 80mg/250mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Atnospas MF 80mg/250mg Tablet use while breastfeeding is absent. Seek medical advice.

DrivingDrivingUNSAFE

Driving ability may be impaired by Atnospas MF 80mg/250mg Tablets, a potential side effect of this medication due to the risk of dizziness.

KidneyKidneyCAUTION

Patients with kidney impairment should use Atnospas MF 80mg/250mg Tablets cautiously, potentially requiring dosage modification. Consult a physician. Atnospas MF 80mg/250mg Tablets are contraindicated in individuals with severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Atnospas MF 80mg/250mg tablets. Dosage modification may be necessary; physician consultation is advised.

What if you forget to take Atnospas MF 80mg/250mg Tablet :

Should you forget to take your Atnospas MF 80mg/250mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Atnospas MF 80mg/250mg Tablet

LabelValue
Developing Habits No.
Treatment Category Gastrointestinal system

FAQs on Atnospas MF 80mg/250mg Tablet

Atnospas MF 80mg/250mg tablets combine drotaverine and mefenamic acid to alleviate abdominal pain. Drotaverine relaxes abdominal smooth muscle spasms, while mefenamic acid reduces pain and inflammation by inhibiting the release of pain-causing chemicals.
Atnospas MF 80mg/250mg tablets are generally safe for abdominal pain, but may cause side effects such as nausea, vomiting, heartburn, diarrhea, appetite loss, dry mouth, weakness, and drowsiness. Less common or rare side effects are also possible. Report any persistent issues to your doctor immediately.
Atnospas MF 80mg/250mg Tablets are typically used for short-term pain relief and can be stopped once pain subsides. However, follow your doctor's instructions regarding continued use.
Atnospas MF 80mg/250mg Tablets may cause nausea and vomiting. To minimize this, take the tablets with food, milk, or an antacid. If vomiting occurs, sip small amounts of water or other fluids frequently. Avoid fatty or fried foods while taking this medication. Persistent vomiting or dehydration symptoms (reduced urination, dark or strong-smelling urine) require immediate medical attention. Do not take other medications without your doctor's approval.
Dry mouth is a possible side effect of Atnospas MF 80mg/250mg Tablets. To alleviate this, drink water frequently throughout the day and keep a glass by your bedside. Use lip balm for dry lips, and avoid spicy, salty, and acidic foods such as lemons.
Avoid exceeding the recommended Atnospas MF 80mg/250mg Tablet dosage; higher doses increase side effect risks. Consult your doctor if pain worsens or remains unrelieved by the prescribed dose.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Atnospas MF 80mg/250mg Ta...
61
MRP 71
14% off